Cardiovascular Drugs and Therapy is a bimonthly peer-reviewed medical journal covering pharmacotherapy as it relates to cardiology. It was established in 1987 and is published by Springer Science+Business Media on behalf of the International Society of Cardiovascular Pharmacotherapy, of which it is the official journal. The editors-in-chief are Willem J. Remme (Carol Davila University of Medicine and Pharmacy) and Robert S. Rosenson (Icahn School of Medicine at Mount Sinai).

Scope of the Report:

This report focuses on the Cardiovascular Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Geographically, North America captured lion’s share of global cardiovascular drugs market in 2016. However increasing adoption of generics in the U.S. is key concern area among key players. Asia Pacific market is projected to gain market share during the forecast period and is likely to be key revenue generator in the coming years. Initiatives by local governments to attain self-sufficiency in manufacturing pharmaceuticals and incentives for generic production in countries such as Brazil, South Africa, Saudi Arabia, etc. is likely to boost market growth in Latin America and Middle East & Africa.

The worldwide market for Cardiovascular Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Amgen

AstraZeneca

Bayer

Bristol Myers Squibb and Pfizer

Daiichi Sankyo

Johnson & Johnson

Merck & Co.

Novartis

Pfizer

Portola

Sanofi

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Renin-Angiotensin System Blockers

Beta Blockers

Diuretics

Anti-Clotting Agents

Antihyperlipidemic

Market Segment by Applications, can be divided into

Hypertension

Hyperlipidemia

There are 15 Chapters to deeply display the global Cardiovascular Drugs market.

Chapter 1, to describe Cardiovascular Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cardiovascular Drugs, with sales, revenue, and price of Cardiovascular Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cardiovascular Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cardiovascular Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cardiovascular Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Cardiovascular Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Renin-Angiotensin System Blockers

1.2.2 Beta Blockers

1.2.3 Diuretics

1.2.4 Anti-Clotting Agents

1.2.5 Antihyperlipidemic

1.3 Market Analysis by Applications

1.3.1 Hypertension

1.3.2 Hyperlipidemia

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Business Overview

2.1.2 Cardiovascular Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen Cardiovascular Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca

2.2.1 Business Overview

2.2.2 Cardiovascular Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca Cardiovascular Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bayer

2.3.1 Business Overview

2.3.2 Cardiovascular Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bayer Cardiovascular Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Bristol Myers Squibb and Pfizer

2.4.1 Business Overview

2.4.2 Cardiovascular Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bristol Myers Squibb and Pfizer Cardiovascular Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Daiichi Sankyo

2.5.1 Business Overview

2.5.2 Cardiovascular Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Daiichi Sankyo Cardiovascular Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Johnson & Johnson

2.6.1 Business Overview

2.6.2 Cardiovascular Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Johnson & Johnson Cardiovascular Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Merck & Co.

2.7.1 Business Overview

2.7.2 Cardiovascular Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Merck & Co. Cardiovascular Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Novartis

2.8.1 Business Overview

2.8.2 Cardiovascular Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Novartis Cardiovascular Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Pfizer

2.9.1 Business Overview

2.9.2 Cardiovascular Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Pfizer Cardiovascular Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Portola

2.10.1 Business Overview

2.10.2 Cardiovascular Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Portola Cardiovascular Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Sanofi

2.11.1 Business Overview

2.11.2 Cardiovascular Drugs Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Sanofi Cardiovascular Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cardiovascular Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Cardiovascular Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Cardiovascular Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Cardiovascular Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Cardiovascular Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Cardiovascular Drugs Market Analysis by Regions

4.1 Global Cardiovascular Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Cardiovascular Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Cardiovascular Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Cardiovascular Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Cardiovascular Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Cardiovascular Drugs Sales and Growth Rate (2013-2018)

4.5 South America Cardiovascular Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Cardiovascular Drugs Sales and Growth Rate (2013-2018)

5 North America Cardiovascular Drugs by Countries

5.1 North America Cardiovascular Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Cardiovascular Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Cardiovascular Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Cardiovascular Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Cardiovascular Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Cardiovascular Drugs Sales and Growth Rate (2013-2018)

6 Europe Cardiovascular Drugs by Countries

6.1 Europe Cardiovascular Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Cardiovascular Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Cardiovascular Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Cardiovascular Drugs Sales and Growth Rate (2013-2018)

6.3 UK Cardiovascular Drugs Sales and Growth Rate (2013-2018)

6.4 France Cardiovascular Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Cardiovascular Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Cardiovascular Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Cardiovascular Drugs by Countries

7.1 Asia-Pacific Cardiovascular Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Cardiovascular Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Cardiovascular Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Cardiovascular Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Cardiovascular Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Cardiovascular Drugs Sales and Growth Rate (2013-2018)

7.5 India Cardiovascular Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Cardiovascular Drugs Sales and Growth Rate (2013-2018)

8 South America Cardiovascular Drugs by Countries

8.1 South America Cardiovascular Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Cardiovascular Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Cardiovascular Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Cardiovascular Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Cardiovascular Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Cardiovascular Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Cardiovascular Drugs by Countries

9.1 Middle East and Africa Cardiovascular Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Cardiovascular Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Cardiovascular Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Cardiovascular Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Cardiovascular Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Cardiovascular Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Cardiovascular Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Cardiovascular Drugs Sales and Growth Rate (2013-2018)

10 Global Cardiovascular Drugs Market Segment by Type

10.1 Global Cardiovascular Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Cardiovascular Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Cardiovascular Drugs Revenue and Market Share by Type (2013-2018)

10.2 Renin-Angiotensin System Blockers Sales Growth and Price

10.2.1 Global Renin-Angiotensin System Blockers Sales Growth (2013-2018)

10.2.2 Global Renin-Angiotensin System Blockers Price (2013-2018)

10.3 Beta Blockers Sales Growth and Price

10.3.1 Global Beta Blockers Sales Growth (2013-2018)

10.3.2 Global Beta Blockers Price (2013-2018)

10.4 Diuretics Sales Growth and Price

10.4.1 Global Diuretics Sales Growth (2013-2018)

10.4.2 Global Diuretics Price (2013-2018)

10.5 Anti-Clotting Agents Sales Growth and Price

10.5.1 Global Anti-Clotting Agents Sales Growth (2013-2018)

10.5.2 Global Anti-Clotting Agents Price (2013-2018)

10.6 Antihyperlipidemic Sales Growth and Price

10.6.1 Global Antihyperlipidemic Sales Growth (2013-2018)

10.6.2 Global Antihyperlipidemic Price (2013-2018)

11 Global Cardiovascular Drugs Market Segment by Application

11.1 Global Cardiovascular Drugs Sales Market Share by Application (2013-2018)

11.2 Hypertension Sales Growth (2013-2018)

11.3 Hyperlipidemia Sales Growth (2013-2018)

12 Cardiovascular Drugs Market Forecast (2018-2023)

12.1 Global Cardiovascular Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Cardiovascular Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Cardiovascular Drugs Market Forecast (2018-2023)

12.2.2 Europe Cardiovascular Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Cardiovascular Drugs Market Forecast (2018-2023)

12.2.4 South America Cardiovascular Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Cardiovascular Drugs Market Forecast (2018-2023)

12.3 Cardiovascular Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Cardiovascular Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Cardiovascular Drugs Market Share Forecast by Type (2018-2023)

12.4 Cardiovascular Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Cardiovascular Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Cardiovascular Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Cardiovascular Drugs Picture

Table Product Specifications of Cardiovascular Drugs

Figure Global Sales Market Share of Cardiovascular Drugs by Types in 2017